Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity-Reference-Cited by-同舟云学术

Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity

Published:2024-02 Issue: Volume:170 Page:105621
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Cheng Samuel M.S.,Lau Jonathan J.,Tsang Leo C.H.,Leung Kathy,Lee Cheuk Kwong,Hachim Asmaa,Kavian Niloufar,Chaothai Sara,Wong Ricky W.K.,Yu Jennifer K.M.,Chai Zacary Y.H.,Mori Masashi,Wu Chao,Yiu Karen,Hui David S.C.,Amarasinghe Gaya K.,Poon Leo L.M.,Wu Joseph T.,Valkenburg Sophie A.,Peiris Malik^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference17 articles.

1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

2. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection;Hachim;Nat. Immunol.,2020

3. SARS-CoV-2 accessory proteins reveal distinct serological signatures in children;Hachim;Nat. Commun.,2022

4. Detection of anti-NS1 antibodies after pandemic influenza exposure: evaluation of a serological method for distinguishing H1N1pdm09 infected from vaccinated cases;Robertson;Influenza Other Respir. Viruses,2020

5. Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain;Wu;iScience,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2;Nature Communications;2024-08-27

2. Differentiation between mpox infection and MVA immunization by a novel machine learning-supported serological multiplex assay;2024-08-09

3. Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination;Virology Journal;2024-03-21